The clinical information you need, at your fingertips.

This rare rodent-borne viral illness is marked by rapid progression from flu-like symptoms to life-threatening cardiopulmonary failure. . .

Two phase 3b trials show that patients can hold most of their GLP-1 weight loss on a reduced injectable dose or by switching to a pill. . .

The agency is seeking drug candidates with existing evidence to support new uses, particularly in disease areas where commercial incentives for label expansion are limited. . .

A single screening sigmoidoscopy reduced colorectal cancer incidence and death over more than two decades in a large Norwegian trial, with substantially larger benefits in men than women. . .

Ocrevus (ocrelizumab) becomes the first high-efficacy anti-CD20 therapy approved for children and adolescents with relapsing-remitting multiple sclerosis, expanding options beyond fingolimod. . .

This is the first artificial intelligence tool cleared to screen for sepsis before clinical suspicion, targeting one of the most lethal and frequently missed in-hospital diagnoses. . .

Prescriptions for ivermectin plus a benzimidazole agent rose sharply after a January 2025 podcast appearance promoted the pairing as a cancer treatment, with the steepest increases among cancer patients. . .

A real-world study found that endoscopic sleeve gastroplasty (ESG) produced about 4 percentage points more weight loss at six months than oral semaglutide in adults with obesity. . .

What began as one investigation spanning 13 states in April has expanded to three multistate outbreaks and 184 illnesses, with 53 hospitalizations and one death. . .